PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1485249
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1485249
Bionic Eye Market - By Eye Type, Technology, Indication, End-use - Global Forecast, 2024 - 2032
Global Bionic Eye Market Size will grow at 11.6% CAGR between 2024 and 2032, owing to technological advancements and the availability of customization options.
With ongoing innovations in microelectronics and robotics, bionic eyes offer improved vision capabilities. Moreover, patients now have a wide range of customization options for their implants, including color selection and design. This personalization enhances patient satisfaction and encourages adoption. As awareness grows and more individuals seek enhanced vision solutions, the combination of advanced technology and customization will drive significant expansion in the bionic eye industry. For instance, in August 2023, HumanOptics introduced a novel premium iris implant, expanding its color selection range with innovative options for patients' customization.
The bionic eye market is segmented based on eye type, technology, indication, end-use, and region.
The mechanical segment will exhibit a healthy growth rate through 2032 due to the mechanical bionic eye's robust performance and long-standing reliability. With their durable and proven designs, mechanical bionic eyes offer a stable option for vision restoration. As advancements in biomechanics continue to enhance the functionality and longevity of mechanical implants, they remain a popular choice among patients and clinicians. With a focus on providing dependable and effective vision solutions, the mechanical segment will capture a significant bionic eye market share.
The ophthalmic clinic segment will garner notable gains over 2024-2032, driven by the pivotal role of ophthalmic clinics in providing access to and facilitating the adoption of these advanced visual prosthetics. These clinics serve as essential hubs for bionic eye implantation surgeries, patient consultations, and post-operative care. With a focus on eye health and vision restoration, ophthalmic clinics are at the forefront of bionic eye innovation. Their expertise, specialized facilities, and comprehensive patient support contribute to the segment's largest share, meeting the increasing demand for vision-enhancing technologies.
Asia Pacific bionic eye industry will demonstrate a noteworthy CAGR between 2024 and 2032, driven by its vast population, increasing healthcare expenditure, and rising prevalence of visual impairments. Countries like China and Japan are prominent in bionic eye research and development. Moreover, the region's aging population fuels the demand for vision-restoring technologies. With a significant focus on healthcare advancements and accessibility, Asia Pacific will emerge as the major contributor to the bionic eye industry, reflecting its crucial role in shaping the future of visual prosthetics.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing prevalence of vision loss and other chronic eye diseases
- 3.2.1.2 Increasing funding by private and public organizations
- 3.2.1.3 Rapid advancements in technological developments
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Low awareness among target population
- 3.2.2.2 High costs associated with these procedures
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Eye Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 External eye
- 5.3 Implanted eye
Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Electronic
- 6.3 Mechanical
- 6.4 Other technologies
Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Vision loss and impairment
- 7.3 Retinitis pigmentosa
- 7.4 Dry age-related macular degeneration
- 7.5 Other indications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Ophthalmic clinics
- 8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Bionic Eye Technologies, Inc.
- 10.2 Bionic Vision Technologies
- 10.3 iBionics
- 10.4 Monash Vision Group
- 10.5 Nidek Co. Ltd.
- 10.6 Optobionics
- 10.7 Pixium Vision SA
- 10.8 Schott
- 10.9 Second Sight Medical Products, Inc.
- 10.10 Vivani Medical, Inc.
